Company Logo

Canakinumab

Agricultural Biotechnology

Updated on Jun 1, 2020

View more like this | Visit SHIRLEY, NY | Contact Bella Smith
Image for Canakinumab with ID of: 4248046
Recombinant monoclonal antibody to Human IL1 beta. Canakinumab (INN, trade name Ilaris, previously ACZ885) is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.